Towards a public-facing version of the CanRisk tool: Co-designing, developing and evaluating MyCanRisk

The CanRisk tool allows healthcare professionals to calculate validated multifactorial estimates of breast, ovarian, and prostate cancer risk. To support patient involvement in risk assessment, we co-designed a public-facing tool, MyCanRisk, which allows patients to collect and share risk information in advance of a clinical appointment, without generating risk estimates. This study describes the user-centred development of MyCanRisk and its initial evaluation. Development involved co-design workshops with patients, public contributors, healthcare professionals, and researchers, followed by iterative accessibility and usability testing against WCAG 2.2. Evaluation used a multi-methods design: 51 women with a family history of breast cancer completed MyCanRisk and, approximately two weeks later, a structured clinical-style interview. Agreement in risk categorisation was assessed using Cohen's kappa. Semi-structured interviews with a purposive subsample (n=15) explored user experiences. MyCanRisk was perceived as accessible and easy to use. Agreement between MyCanRisk and structured interviews for risk categorisation was substantial (κ = 0.81, 95% CI 0.65-0.97). Discrepancies mainly reflected difficulties recalling detailed family history, such as ages at diagnosis and dates of birth/death. Participants valued the stepwise flow and asynchronous completion but reported challenges when their knowledge was incomplete. Suggested improvements included options to record approximate or unknown data and greater flexibility to update submissions. MyCanRisk has the potential to reduce data collection burden during clinical encounters, support patient preparation for risk assessment, and streamline cancer risk assessment pathways. With further refinement and testing in more diverse populations, it may facilitate earlier identification of individuals at increased cancer risk.

Authors

Institutions

Publication Details

Journal
Cancer Prevention Research
Published
2026-11-03
DOI
https://doi.org/10.1158/1940-6207.capr-26-0084
Primary Topic
Patient-Provider Communication in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Towards a public-facing version of the CanRisk tool: Co-designing, developing and evaluating MyCanRisk

Lorenzo Ficorella, Nichola Fennell, Cameron Wilson, Fiona Mary Walter et al.
2 links
Cancer Prevention Research
Patient-Provider Communication in Healthcare
article

Towards a public-facing version of the CanRisk tool: Co-designing, developing and evaluating MyCanRisk

Lorenzo Ficorella, Nichola Fennell, Cameron Wilson, Fiona Mary Walter, Antonis C. Antoniou, Francisca Stutzin Donoso, Juliet A. Usher‐Smith, Douglas F. Easton, Cameron Wilson, Marc D. Tischkowitz, Jon David Emery, Leila Dorling, Stephanie Archer, Douglas Easton, antonis Antoniou, Jon Emery, Nichola Fennell, Tim Carver, Marc Tischkowitz, Fiona Walter, Leila Wilson
article en

Abstract

The CanRisk tool allows healthcare professionals to calculate validated multifactorial estimates of breast, ovarian, and prostate cancer risk. To support patient involvement in risk assessment, we co-designed a public-facing tool, MyCanRisk, which allows patients to collect and share risk information in advance of a clinical appointment, without generating risk estimates. This study describes the user-centred development of MyCanRisk and its initial evaluation. Development involved co-design workshops with patients, public contributors, healthcare professionals, and researchers, followed by iterative accessibility and usability testing against WCAG 2.2. Evaluation used a multi-methods design: 51 women with a family history of breast cancer completed MyCanRisk and, approximately two weeks later, a structured clinical-style interview. Agreement in risk categorisation was assessed using Cohen's kappa. Semi-structured interviews with a purposive subsample (n=15) explored user experiences. MyCanRisk was perceived as accessible and easy to use. Agreement between MyCanRisk and structured interviews for risk categorisation was substantial (κ = 0.81, 95% CI 0.65-0.97). Discrepancies mainly reflected difficulties recalling detailed family history, such as ages at diagnosis and dates of birth/death. Participants valued the stepwise flow and asynchronous completion but reported challenges when their knowledge was incomplete. Suggested improvements included options to record approximate or unknown data and greater flexibility to update submissions. MyCanRisk has the potential to reduce data collection burden during clinical encounters, support patient preparation for risk assessment, and streamline cancer risk assessment pathways. With further refinement and testing in more diverse populations, it may facilitate earlier identification of individuals at increased cancer risk.

Cancer Prevention Research
Queen Mary University of London (GB), Nanyang Technological University (SG), University of Cambridge (GB), Cambridge School (PT), Bridge University (SS)
Good health and well-being, Reduced inequalities
Openalex Percentile: Top 12%
Patient-Provider Communication in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon